Trials / Completed
CompletedNCT00233506
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated
A Dose-Finding Study of CpG 7909 in Previously Treated Chronic Lymphocytic Leukemia
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- University of Iowa · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
* CpG has the potential to stimulate the immune system * this study will evaluate the safety of CpG given sub-q or IV * purpose is to measure biological changes in CLL cells after receiving CpG
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CpG 7909 |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2005-10-05
- Last updated
- 2017-02-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00233506. Inclusion in this directory is not an endorsement.